Medicamentos potencialmente inapropriados utilizados por idosos da Estratégia de Saúde da Família de São João del-Rei
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Human aging affects the body's pharmacokinetic and pharmacodynamic responses,
thus medication safety is of utmost importance emphasizing the use of Potentially
Inappropriate Medications (PIM) for older people. Despite multiple studies evaluating
clinical outcomes and economic impacts related to PIM use, there is a lack of
longitudinal studies assessing the 2023 updated Beers criteria. This study examined
the use and factors associated with PIM use by the elderly people into the community
following the 2019 and 2023 Beers criteria and evaluated predictive value of these
criteria in different clinical outcomes at one-year follow-up. It is a population-based
longitudinal study one-year follow-up from 2017 to 2018 with 490 older adults under
the Family Health Strategy in São João del-Rei, Brazil. The Beers criteria, versions
2019 and 2023, were used to identify PIM. Different health outcomes were assessed,
such as cognition (as measured by Mini-Mental State Examination), sleep (evaluated
using the Mini-Sleep questionnaire), mental health (assessed via the DASS-21),
quality of life (gauged using the WHOQOL-Bref), successful aging (measured with the
Successful Aging Scale) and life satisfaction (evaluated through the Life Satisfaction
Scale). Generalized Estimating Equations were used to evaluate if the presence of PIM
was longitudinally associated with diverse outcomes following the one-year follow-up
period. A total of 255 (52%) of the elderly used at least 1 PIM. There were slight
differences between two criteria (2019 and 2023) among elderly people into the
community. The most common PIM were benzodiazepines, followed by Proton pump
inhibitors and Sulfonylureas. We found that some sociodemographic factors (e.g.
marital status and race) and clinical factors (e.g. difficulties in ADLs and number of
diseases) were associated with the presence or number of PIM at baseline. In the
longitudinal analysis, the presence of PIM exhibited associations with a spectrum of
outcomes observed after one-year of follow up period. These outcomes included
diminished physical quality of life, disrupted sleep patterns, compromised mental
health (depression, stress and anxiety), successful aging and satisfaction with life. The
conclusion is that the use of at least one PIM according to the Beers 2023 criteria was
high and predictive of worse health outcomes. This underscores the imperative for
healthcare professionals to exercise caution when prescribing a medications to their
elderly patients.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Embargado

